Market Closed -
Other stock markets
|
After hours 21:01:57 | |||
27.53 EUR | +0.51% |
|
27.64 | +0.42% |
10:42am | ZALANDO : Receives a Buy rating from Warburg Research | ZD |
07-15 | ZALANDO : UBS reiterates its Buy rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.7 | 3.84 | 0.7 | 1.81 | 3.11 | |||||
Return on Total Capital | 8.27 | 6.66 | 1.31 | 3.43 | 5.69 | |||||
Return On Equity % | 11.79 | 10.73 | 0.76 | 3.63 | 9.97 | |||||
Return on Common Equity | 11.79 | 10.73 | 0.76 | 3.63 | 9.97 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 43.03 | 41.78 | 39.2 | 38.75 | 40.69 | |||||
SG&A Margin | 38.03 | 37.89 | 38.55 | 36.49 | 36.99 | |||||
EBITDA Margin % | 6.14 | 4.83 | 1.98 | 3.58 | 5.06 | |||||
EBITA Margin % | 5.19 | 4.04 | 0.93 | 2.34 | 3.84 | |||||
EBIT Margin % | 5.1 | 3.97 | 0.78 | 2.2 | 3.71 | |||||
Income From Continuing Operations Margin % | 2.83 | 2.26 | 0.16 | 0.82 | 2.38 | |||||
Net Income Margin % | 2.83 | 2.26 | 0.16 | 0.82 | 2.38 | |||||
Net Avail. For Common Margin % | 2.83 | 2.26 | 0.16 | 0.82 | 2.38 | |||||
Normalized Net Income Margin | 2.81 | 2.06 | 0.23 | 1.14 | 2.18 | |||||
Levered Free Cash Flow Margin | 3.43 | 2.62 | 0.46 | 7.02 | 3.04 | |||||
Unlevered Free Cash Flow Margin | 3.88 | 2.97 | 0.84 | 7.55 | 3.59 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.47 | 1.55 | 1.42 | 1.32 | 1.34 | |||||
Fixed Assets Turnover | 7.52 | 8.82 | 7.6 | 6.56 | 6.6 | |||||
Receivables Turnover (Average Receivables) | 14.99 | 15.57 | 13.91 | 14.95 | 17.76 | |||||
Inventory Turnover (Average Inventory) | 3.7 | 4.14 | 3.75 | 3.82 | 4.19 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.68 | 1.61 | 1.44 | 1.49 | 1.37 | |||||
Quick Ratio | 1.16 | 1.06 | 0.89 | 1.04 | 0.94 | |||||
Operating Cash Flow to Current Liabilities | 0.18 | 0.2 | 0.13 | 0.27 | 0.16 | |||||
Days Sales Outstanding (Average Receivables) | 24.41 | 23.44 | 26.24 | 24.41 | 20.61 | |||||
Days Outstanding Inventory (Average Inventory) | 98.97 | 88.06 | 97.41 | 95.48 | 87.28 | |||||
Average Days Payable Outstanding | 142.99 | 131.8 | 149.62 | 178.5 | 158.55 | |||||
Cash Conversion Cycle (Average Days) | -19.6 | -20.29 | -25.97 | -58.61 | -50.67 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 82.2 | 70.98 | 78.06 | 78.02 | 64.74 | |||||
Total Debt / Total Capital | 45.11 | 41.52 | 43.84 | 43.83 | 39.3 | |||||
LT Debt/Equity | 61.21 | 66.43 | 72.16 | 72.45 | 44.37 | |||||
Long-Term Debt / Total Capital | 33.6 | 38.85 | 40.53 | 40.7 | 26.93 | |||||
Total Liabilities / Total Assets | 66.88 | 67.83 | 71.16 | 69.54 | 66.62 | |||||
EBIT / Interest Expense | 7 | 6.93 | 1.29 | 2.61 | 4.2 | |||||
EBITDA / Interest Expense | 9.67 | 9.94 | 5.32 | 5.74 | 7.21 | |||||
(EBITDA - Capex) / Interest Expense | 6.62 | 5.88 | 0.94 | 3.52 | 5.92 | |||||
Total Debt / EBITDA | 3.14 | 2.67 | 5.15 | 3.77 | 2.56 | |||||
Net Debt / EBITDA | -1.56 | -1.21 | -0.96 | -1.56 | -1.41 | |||||
Total Debt / (EBITDA - Capex) | 4.59 | 4.52 | 29.05 | 6.15 | 3.12 | |||||
Net Debt / (EBITDA - Capex) | -2.28 | -2.04 | -5.44 | -2.55 | -1.72 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 23.13 | 29.72 | -0.09 | -1.95 | 4.23 | |||||
Gross Profit, 1 Yr. Growth % | 24.05 | 27.46 | -6.26 | -3.08 | 9.45 | |||||
EBITDA, 1 Yr. Growth % | 91.11 | 11.18 | -60.21 | 77.8 | 47.11 | |||||
EBITA, 1 Yr. Growth % | 115.51 | 12.04 | -77.84 | 148.23 | 70.69 | |||||
EBIT, 1 Yr. Growth % | 127.74 | 12.04 | -80.93 | 175.68 | 75.5 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 126.78 | 3.72 | -92.84 | 394.05 | 202.53 | |||||
Net Income, 1 Yr. Growth % | 126.78 | 3.72 | -92.84 | 394.05 | 202.53 | |||||
Normalized Net Income, 1 Yr. Growth % | 127.03 | 6.94 | -89.05 | 377.58 | 98.6 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 120.51 | 2.33 | -93.18 | 432.66 | 200.38 | |||||
Accounts Receivable, 1 Yr. Growth % | 30.3 | 20.73 | 4.47 | -21.49 | -0.45 | |||||
Inventory, 1 Yr. Growth % | 23.94 | 13.68 | 16.94 | -20.37 | 7.55 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 9.96 | 11.14 | 20.5 | 7.88 | -0.59 | |||||
Total Assets, 1 Yr. Growth % | 49.89 | 6.19 | 10.57 | 2.15 | 2.49 | |||||
Tangible Book Value, 1 Yr. Growth % | 27.45 | 3.31 | -7.54 | 9.53 | 13.89 | |||||
Common Equity, 1 Yr. Growth % | 27.76 | 3.15 | -0.89 | 7.91 | 12.31 | |||||
Cash From Operations, 1 Yr. Growth % | 61.19 | 16.84 | -25.37 | 106.46 | -31.11 | |||||
Capital Expenditures, 1 Yr. Growth % | -24.01 | 35.36 | 14.18 | -30.6 | -36.69 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -2.61K | 8.92 | -83.05 | 1.4K | -54.91 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 4.06K | 8.04 | -72.65 | 784.56 | -50.44 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 21.72 | 26.38 | 13.84 | -1.02 | 1.09 | |||||
Gross Profit, 2 Yr. CAGR % | 22.71 | 25.01 | 9.31 | -4.69 | 2.99 | |||||
EBITDA, 2 Yr. CAGR % | 68.48 | 39.66 | -32.59 | -15.89 | 61.73 | |||||
EBITA, 2 Yr. CAGR % | 81.12 | 47.65 | -49.38 | -25.84 | 105.84 | |||||
EBIT, 2 Yr. CAGR % | 84.83 | 51.65 | -53.02 | -27.5 | 119.96 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 110.14 | 53.36 | -72.74 | -40.51 | 286.61 | |||||
Net Income, 2 Yr. CAGR % | 109.73 | 53.36 | -72.74 | -40.51 | 286.61 | |||||
Normalized Net Income, 2 Yr. CAGR % | 84.02 | 46.82 | -65.1 | -27.67 | 207.97 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 107.36 | 50.21 | -73.59 | -39.74 | 300 | |||||
Accounts Receivable, 2 Yr. CAGR % | 23.49 | 25.42 | 12.31 | -9.44 | -11.59 | |||||
Inventory, 2 Yr. CAGR % | 28.88 | 18.7 | 15.3 | -3.5 | -7.46 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 68.12 | 10.55 | 15.73 | 14.02 | 3.56 | |||||
Total Assets, 2 Yr. CAGR % | 41.72 | 26.16 | 8.36 | 6.27 | 2.32 | |||||
Tangible Book Value, 2 Yr. CAGR % | 18.3 | 14.75 | -2.26 | 0.64 | 11.69 | |||||
Common Equity, 2 Yr. CAGR % | 17.84 | 14.79 | 1.11 | 3.41 | 10.09 | |||||
Cash From Operations, 2 Yr. CAGR % | 57.43 | 37.23 | -6.62 | 24.13 | 19.26 | |||||
Capital Expenditures, 2 Yr. CAGR % | -11.37 | 1.42 | 24.32 | -10.98 | -33.72 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 165.65 | 397.9 | -56.37 | 59.64 | 160.39 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 152.6 | 542.88 | -44.9 | 55.53 | 109.38 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 21.15 | 24.33 | 16.86 | 8.31 | 0.7 | |||||
Gross Profit, 3 Yr. CAGR % | 20.57 | 23.79 | 13.57 | 5.01 | -0.19 | |||||
EBITDA, 3 Yr. CAGR % | 29.39 | 42.55 | -7.27 | -6.86 | 1.34 | |||||
EBITA, 3 Yr. CAGR % | 28.64 | 49.16 | -20.7 | -13.99 | -2.09 | |||||
EBIT, 3 Yr. CAGR % | 29.48 | 51.1 | -23.2 | -15.26 | -2.65 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 30.6 | 66.07 | -44.77 | -28.4 | 2.31 | |||||
Net Income, 3 Yr. CAGR % | 29.92 | 65.85 | -44.77 | -28.4 | 2.31 | |||||
Normalized Net Income, 3 Yr. CAGR % | 26.39 | 47.6 | -37.38 | -16.52 | 1.28 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 29.07 | 63.86 | -46.42 | -28.1 | 2.94 | |||||
Accounts Receivable, 3 Yr. CAGR % | 29.3 | 22.56 | 18.01 | -0.33 | -6.54 | |||||
Inventory, 3 Yr. CAGR % | 20.45 | 23.6 | 18.11 | 1.91 | 0.05 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 68.01 | 46.45 | 13.77 | 13.05 | 8.93 | |||||
Total Assets, 3 Yr. CAGR % | 29.65 | 28.72 | 20.74 | 6.25 | 5 | |||||
Tangible Book Value, 3 Yr. CAGR % | 12.32 | 13.08 | 6.78 | 1.52 | 4.88 | |||||
Common Equity, 3 Yr. CAGR % | 11.81 | 12.73 | 9.31 | 3.32 | 6.3 | |||||
Cash From Operations, 3 Yr. CAGR % | 39.64 | 42.53 | 12.02 | 21.65 | 2.01 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.07 | 2.07 | 5.51 | 2.36 | -20.54 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 29.26 | 91.13 | 63.03 | 41.99 | 4.74 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 38.1 | 85.04 | 126.46 | 39 | 6.23 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 21.96 | 23.26 | 18.17 | 13.49 | 10.28 | |||||
Gross Profit, 5 Yr. CAGR % | 20.82 | 21.87 | 15.66 | 11.5 | 9.22 | |||||
EBITDA, 5 Yr. CAGR % | 34.47 | 17.49 | -2.01 | 16.06 | 15.83 | |||||
EBITA, 5 Yr. CAGR % | 34.01 | 15.57 | -13.21 | 13.51 | 16.14 | |||||
EBIT, 5 Yr. CAGR % | 35.39 | 15.93 | -15.46 | 13.38 | 16.99 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 13.23 | 14.24 | -30.21 | 10.14 | 20.29 | |||||
Net Income, 5 Yr. CAGR % | 13.23 | 14.24 | -30.43 | 10.06 | 20.29 | |||||
Normalized Net Income, 5 Yr. CAGR % | 32.87 | 13.3 | -26.24 | 11.84 | 18.42 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.37 | 13.36 | -31.57 | 9.83 | 19.74 | |||||
Accounts Receivable, 5 Yr. CAGR % | 32.11 | 27.49 | 22.21 | 8.59 | 5.13 | |||||
Inventory, 5 Yr. CAGR % | 22.5 | 21.81 | 18.36 | 11.95 | 7.13 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 57.28 | 50.75 | 44.73 | 32.5 | 9.57 | |||||
Total Assets, 5 Yr. CAGR % | 25.14 | 22.13 | 20.67 | 19.22 | 13 | |||||
Tangible Book Value, 5 Yr. CAGR % | 10.48 | 9.18 | 6.25 | 7.93 | 8.72 | |||||
Common Equity, 5 Yr. CAGR % | 11.09 | 9.53 | 7.4 | 8.9 | 9.62 | |||||
Cash From Operations, 5 Yr. CAGR % | 34.59 | 17.44 | 18.88 | 34.87 | 14.86 | |||||
Capital Expenditures, 5 Yr. CAGR % | 41.78 | 14.51 | 7.74 | -3.37 | -12.39 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 40.65 | 35.01 | -17.88 | 78.95 | 96.61 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 42.09 | 35.36 | -5.98 | 73.56 | 119.47 |
- Stock Market
- Equities
- ZAL Stock
- Financials Zalando SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition